Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Vanguard Total International Stock Index Fund ETF (VXUS) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance

Vanguard Total International Stock Index Fund ETFTrade
Health Care Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

Vanguard Total International Stock Index Fund ETF vs Health Care Select Sector SPDR Fund — how do they compare? Vanguard Total International Stock Index Fund ETF trades at $84.61 (market cap $665.70B), while Health Care Select Sector SPDR Fund trades at $169.85 (market cap $43.48B). The key difference: Vanguard Total International Stock Index Fund ETF is far larger — about 15.3× Health Care Select Sector SPDR Fund's market cap, and Health Care Select Sector SPDR Fund is more actively traded (11,121,431 versus 4,864,744). Which is the better fit depends on your goals — on Pluang, investors hold Vanguard Total International Stock Index Fund ETF for 55 Days and Health Care Select Sector SPDR Fund for 100 Days on average.

VXUSXLV
Market Cap
$665.70B$43.48B
Volume
4,864,74411,121,431
Sector
Sector/Thematic—
52-Week High
$88.41$175.68
52-Week Low
$72.17$141.95
Typical Hold Time
55 Days100 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Vanguard Total International Stock Index Fund ETF

VXUS trades at $84.78, down 1.19% with a bearish technical signal from moving averages. The ETF provides broad international stock exposure outside the U.S., with institutional buying interest noted in recent SEC filings. Technical indicators show neutral oscillators but bearish momentum signals from ADX readings.

The fund offers diversification benefits as a core international holding, though recent performance faces headwinds. Key risks include currency fluctuations and emerging market volatility. Long-term outlook remains positive for global equity exposure, supported by Vanguard's low-cost structure and comprehensive market coverage.

Health Care Select Sector SPDR Fund

XLV trades at $169.58 with a slight 0.46% daily gain amid bearish technical signals. The ETF faces selling pressure with moving averages indicating downward momentum while oscillators remain neutral. Recent news highlights XLV's competitive expense ratio of 0.08% and defensive healthcare sector positioning. Options activity shows increased put volume, suggesting some investor caution despite the fund's diversification across 61 healthcare stocks.

The healthcare ETF presents a cost-effective defensive play with potential upside if political volatility subsides post-elections. Key risks include sector-specific regulatory pressures and biotech trial failures impacting holdings. Current technical weakness near support at $166 requires monitoring for potential breakdown, though the fund's low fees and broad diversification provide stability during market uncertainty.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

VXUS
81% Buy19% Sell
Avg holding period · 55 Days
XLV
53% Buy47% Sell
Avg holding period · 100 Days

About Vanguard Total International Stock Index Fund ETF

VXUS is a comprehensive, low-cost ETF that tracks the FTSE Global All Cap ex US Index, providing exposure to over 8,500 stocks in both developed and emerging markets outside the United States. It serves as a foundational building block for international diversification, allowing investors to own a market-cap-weighted slice of the entire non-U.S. investable equity universe in a single vehicle.

Read more on VXUS →

About Health Care Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Read more on XLV →